Head-to-head · Value Score
bmiMD vs Superior Remedies
Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Superior Remedies a 62. Here's who gives you the honest lower price — and where each one bites back.
bmiMD
#9 · Grade A · Great Deal
Est. first month
$99/mo
Save ~93% vs brand-nameSuperior Remedies
#336 · Grade C · Watch List
Est. first month
Not disclosed
The verdict
bmiMD takes it on Value Score, 89 to 62 — an est. $99/mo first month, with no teaser step-up baked in. Superior Remedies isn't out of it: Readers who want a low-dose protocol designed on its own terms rather than a smaller version of a weight-loss plan, and who do not mind starting an eligibility check to learn the price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | bmiMD | Superior Remedies |
|---|---|---|
| Value Score | 89 (A) | 62 (C) |
| Est. first month | $99/mo | Not disclosed |
| Save vs brand-name | ~93% | — |
| Semaglutide | $99/mo | Not disclosed |
| Tirzepatide | $139/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states (telehealth nationwide) |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
bmiMD
Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.
Why it's a deal
- $99 flat semaglutide and a low $139 tirzepatide
- Available in all 50 states
- Both molecules priced up front
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Thin public track record; no oral or brand-name option
Superior Remedies
Superior Remedies runs three named programs — semaglutide, tirzepatide, and a dedicated GLP-1 Microdose protocol for longevity and body composition — and publishes no price for any of them.
Why it's a deal
- Runs a dedicated GLP-1 Microdose program with its own page, framed for metabolic health and body composition rather than aggressive weight loss
- Publishes a clinical exclusion that turns business away: patients with significant weight to lose are told they would be better served by a standard GLP-1 protocol
- Charges nothing if you are not approved, and states telehealth availability in all 50 states
- Names its exclusions plainly, including medullary thyroid carcinoma or MEN 2 history and pregnancy
The fine print
- ⚠⚠ No price on any program page — the only public figure is a homepage headline labeled a limited-time offer and attached to the general pitch rather than to a program
- ⚠ No milligram figure anywhere, so "microdose" describes an intent rather than an amount
- No compounding pharmacy is named
- Compounded GLP-1s are not FDA-approved
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives ranking, and the same list for the other side is on alternatives to Superior Remedies.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.